Suppr超能文献

非肝硬化性门静脉高压症

Non-cirrhotic portal hypertension.

作者信息

Sarin Shiv K, Khanna Rajeev

机构信息

Department of Hepatology, Institute of Liver and Biliary Sciences, D-1 Vasant Kunj, New Delhi 110070, India.

Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, D-1 Vasant Kunj, New Delhi 110070, India.

出版信息

Clin Liver Dis. 2014 May;18(2):451-76. doi: 10.1016/j.cld.2014.01.009.

Abstract

Non-cirrhotic portal hypertension (NCPH) encompasses a wide range of disorders, primarily vascular in origin, presenting with portal hypertension (PHT), but with preserved liver synthetic functions and near normal hepatic venous pressure gradient (HVPG). Non-cirrhotic portal fibrosis/Idiopathic PHT (NCPF/IPH) and extrahepatic portal venous obstruction (EHPVO) are two prototype disorders in the category. Etiopathogenesis in both of them centers on infections and prothrombotic states. Presentation and management strategies focus on repeated well tolerated episodes of variceal bleed and moderate to massive splenomegaly and other features of PHT. While the long-term prognosis is generally good in NCPF, portal biliopathy and parenchymal extinction after prolonged PHT makes outcome somewhat less favorable in EHPVO. While hepatic schistosomiasis, congenital hepatic fibrosis and nodular regenerative hyperplasia have their distinctive features, they often present with NCPH.

摘要

非肝硬化性门静脉高压症(NCPH)涵盖多种疾病,主要起源于血管性疾病,表现为门静脉高压(PHT),但肝脏合成功能保留且肝静脉压力梯度(HVPG)接近正常。非肝硬化性门静脉纤维化/特发性门静脉高压症(NCPF/IPH)和肝外门静脉阻塞(EHPVO)是该类别中的两种典型疾病。它们的病因发病机制均以感染和血栓前状态为中心。临床表现和管理策略集中于静脉曲张出血的反复发作且耐受性良好、中度至重度脾肿大以及门静脉高压的其他特征。虽然NCPF的长期预后通常良好,但门静脉胆管病以及长期门静脉高压后的实质萎缩使得EHPVO的预后略差。虽然肝血吸虫病、先天性肝纤维化和结节性再生性增生有其独特特征,但它们常表现为非肝硬化性门静脉高压症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验